FundingAgriculture & Food Systems
BioPrime raises $6 million Series A from Edaphon
By Abha Lohia · Editor ·
BioPrime: funding and every story →
Series APuneFounded 2016
- BioPrime makes biological sprays and soil additives that help crops withstand climate stress
- It raised a $6 Mn Series A led by Belgium-based Edaphon, with Omnivore and Inflexor Ventures
- The company has grown revenue three-fold year-on-year and plans to become profitable next year
What happened
- BioPrime is a Pune-based startup that builds biological agricultural inputs.
- It uses biochemicals and microbes to help crops withstand climatic stress, improve yield quality and soil health.
- The company has raised a $6 Mn Series A round led by Belgium-based Edaphon.
- Existing investors Omnivore and Inflexor Ventures also participated in the round.
- BioPrime has raised a total of $8 Mn to date.
- The company has achieved three-fold year-on-year revenue growth.
- It plans to become profitable next year and focus on international expansion.
Why it matters
- India's biofertiliser market is projected to grow from $165.93 Mn to $253.09 Mn by 2031.
- The biostimulants market is expected to reach $365.38 Mn by 2031 from $230.68 Mn.
- Growth drivers include policy support, rising fertiliser costs, and global demand for residue-free produce.
- BioPrime's technology primes crops in advance using secondary metabolites (alkaloids, terpenes, etc.).
The business
- BioPrime builds biological agri inputs such as sprays and irrigation additives.
- Its patented tech stack includes SNIPR (biomolecules) for immediate protection and BioNexus (microbes) for long-term soil health.
- Products include soil restoration inputs, bio-insecticides, and bio-fungicides.
- The company works with secondary metabolites (alkaloids, terpenes, amines, etc.) to prime crops in advance.
- It has tied up with Yara, ICL Fertilizers, DCM Shriram, and Insecticides India.
- BioPrime uses a 'seeing is believing' adoption strategy with demo farms and side-by-side yield calculations.
The founders
DR
Dr Renuka Diwan
Cofounder- Background in academia and genetic engineering.
- Cofounder of BioPrime.
DA
Dr Amit Shinde
Cofounder- Background in industrial R&D at Kumar Florist.
- Cofounder of BioPrime.
DS
Dr Shekhar Bhosle
Cofounder- Background in startup ecosystem.
- Cofounder of BioPrime.
Who put in money
- Edaphon lead — Belgium-based investor.
- Omnivore participated — Existing investor.
- Inflexor Ventures participated — Existing investor.
In numbers
$8 MnTotal raised · 2026
$6 MnSeries A amount · 2026
three-fold year-on-yearRevenue growth · 2026
$165.93 MnIndia biofertiliser market size · 2026
$253.09 MnIndia biofertiliser market projection · 2031
$230.68 MnIndia biostimulants market size · 2026
$365.38 MnIndia biostimulants market projection · 2031
What happens next
- BioPrime plans to become profitable next year.
- It will focus on international expansion, particularly in the US, Brazil, and Southeast Asia.
Words to know
- Secondary metabolites
- Organic compounds produced by plants that are not directly involved in growth but help in defence and stress response (e.g., alkaloids, terpenes).
- Biofertiliser
- A substance containing living microorganisms that enrich soil nutrients when applied to crops.
- Biostimulant
- A substance that enhances plant growth and stress tolerance without being a fertiliser or pesticide.
- Series A
- The first significant venture capital funding round after seed stage, used to scale operations.
The numbers around it
Agriculture & Food Systems in April 2026: 4 rounds with a disclosed amount, $15.9 million in all; the biggest was BioPrime ($6 Mn). Every sector this year →
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
- Profitability: A path to profitability is the plan and evidence that a startup will earn more than it spends. In India the usual order is contribution positive, then EBITDA positive, then net profit and positive cash flow. Each step is a different test, so claims of profit need the definition.
- Profitability: Profitable can mean five different things in a startup headline: profit after tax, positive EBITDA, positive adjusted EBITDA, positive cash flow or profit on each order. Only the first is a profit in the full accounting sense. Always check which one a story means.
Read next
FundingHenfruit raises $15 million in first outside roundHenfruit sells packaged, graded and lab-tested eggs, and has run on its own money since 2014NewsFarmwiseAI maps 40 million Tamil Nadu land parcelsFarmwiseAI is a Chennai startup, founded around six years ago, that combines artificial intelligence with mapping data to solve farm and land problemsResultsEggoz revenue climbs 39% as losses widenEggoz, a Gurugram brand run by Nupa Technologies, sources eggs from local poultry farmers and supplies retailers within a day
Everything on BioPrime → · All startup news on 7 April 2026 →
Is this BioPrime? Get your “Featured on StopDown” badge →